Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pennsaid Effect on Coagulation in OA Patients on Anticoagulants
NCT01511939Phase 3Completed
- Start
- Feb 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of Elfenor in osteoarthritis (OA) (3 arms). Primary endpoints: Prothrombin Time at 4 weeks, International Normalized Ratio at 4 weeks and 2 more. Started Feb 2012; status: completed.
02
Drugs
Elfenor
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01511939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01511939.